Head-Operations at Matrix Pharma crop Ltd. (2025-02 – 2025-09)
- Administering and responsible for P&L for operations at Visakhapatnam units (03No)
- Front-leading entire gamut of API manufacturing and reporting to CEO-API Business
- Spearheading a team of 1600 associates with excellent people management skills
- Managing turnover of > 2500 Cr. INR/Annum
- Last successful recent USFDA audit faced in 1st to 5th September 2025
Associate Vice President - Operations at Sun Pharmaceuticals Ltd. (2015-12 – 2025-01)
- Worked as cluster head for three plants namely Dewas & Malanpur (both plants in M.P.) and Toansa (Punjab)
- Responsible for the operations of sterile and non-sterile API manufacturing
- Spearheading a team of 1200 associates with excellent people management skills
- Managing turnover of >1500 Cr. INR/Annum
- Drawing production plan, mobilizing and managing manpower, machines and material resources to optimize operational efficiency
- Implementing improvement/modification/remedial projects to meet the latest GMP requirements and enhance process efficiency
- Providing leadership to the team members and integrating team efforts to maximize overall team productivity
- Implementing preventive, predictive and corrective maintenance practices to maximize operational availability of machines and equipment
- Driving process simplification initiatives and aligning cross functional team to achieve the target
- Led successful ANVISA, TGA, PMDA, CFDA (China) and Canada audits
- Improved turnover for all three plants and achieved positive EBITA from negative at the time of taking charge
AVP - Manufacturing at Cadila Pharmaceuticals Ltd. (2015-09 – 2015-12)
- Troubleshot and identified bottlenecks of process issues and drove improvement in yield and quality on continual basis; front-led planning and inventory control in coordination with SCM
- Managed over 300 on-roll and 160 contract manpower with 08 clean rooms, P.E. Lab and worked on process engineering with centralized solvent recovery plant
- Maintained OTIF (92% +5%) as per planning of production and dispatch by proper utilization of man and machines
General Manager - Manufacturing at Harman Finochem Ltd. (2011-05 – 2015-08)
- Got USFDA Approval in 2012 & 2015, KFDA Approval in 2013, German Health in 2013, Cofepris (Mexican) Audit in 2014
- Ensured adherence of OTIF to 92% +5%
- Leveraged excellence in leading erection & commissioning of various machines and equipment to reduce downtime and enhance operational effectiveness of equipment
- Planned & executed projects for plant set up, plant expansion, modernization and installation/ commissioning of equipment
- Enhanced turnover from 15 Cr. to 220Cr.
Deputy General Manager - Production at Glenmark Generics Ltd. (2010-04 – 2011-04)
- Pivotal in USFDA approval and Romania regulatory approval
- Administered multiple products and plants with respect to commissioning new molecules
- Managed approx. 250 associates with 09 manufacturing plants and 01 pilot plant with an average production of 15-20 products in a month
Deputy General Manager - Works at Wanbury Ltd. (2007-07 – 2010-03)
- Received USFDA approval in 2009, German Health Regulatory Approval in 2008
- Promoted from AGM - Works to DGM - Works within a year of joining
- Drove meetings with Labor Unions thus leveraging strong negotiation skills to create a win-win situation for the organization
- Achieved improvement in yields and drove optimization of batch time cycle to increase production volume
- Ensured adherence of OTIF and achieved ESR (Employee Spot Recognition) for various initiatives
- Imparted training on the latest cGMP trends & requirements
Senior Manager - Production at Aurobindo Pharma Ltd. (2003-07 – 2007-06)
Assistant Manager – A&MP Division at Alembic Ltd. (2002-02 – 2003-06)
Assistant Manager - Production at KDL Biotech Ltd. (1996-12 – 2002-01)
Officer – Production at Lupin Laboratories Ltd. (1994-05 – 1996-11)
Supervisor - Production at Camphor & Allied Products Ltd. (1991-11 – 1994-04)
